A recent study challenges the widely held belief that omega-3 supplements are a miracle solution for enhancing brain health. Research conducted by Keck Medicine of the University of Southern California indicates that high doses of omega-3s may not significantly impact cognitive function or protect against brain-related issues, despite evidence of their presence in the brain.
The two-year trial, which involved older adults at heightened risk of Alzheimer’s disease, found that taking omega-3 supplements did not lead to improvements in memory, cognitive abilities, or the prevention of brain cell loss in regions associated with the disease.
Lead researcher Hussein Naji Yassine, MD, emphasized that while omega-3 fatty acids are crucial for brain function, the study’s results do not support the use of fish oil supplements as a preventive measure against Alzheimer’s disease.
The study enrolled 365 participants aged 55 to 80 who had low fish consumption and were at increased risk of Alzheimer’s. Nearly half of the participants carried the APOE4 gene, a significant genetic risk factor for late-onset Alzheimer’s.
Participants were randomly assigned to receive either daily fish oil supplements or a placebo containing 2,000 mg of docosahexaenoic acid (DHA), a key omega-3 fatty acid associated with brain health. While DHA levels in the brain increased by 17% after six months, cognitive tests and brain scans after two years showed no significant differences between the supplement and placebo groups.
Further investigations are underway to understand why omega-3s can reach the brain without producing noticeable benefits. Researchers suggest that incorporating omega-3s into a Mediterranean-style diet, naturally rich in these fatty acids, may be more effective in promoting brain health.
Yassine highlighted the importance of lifestyle factors, such as exercise, quality sleep, and a balanced diet, in supporting brain health and reducing the risk of Alzheimer’s disease. He emphasized that maintaining a healthy lifestyle is crucial for preserving cognitive function and overall well-being.
The study involved researchers from the University of Southern California’s Keck School of Medicine, including Lina D’Orazio, Lon Schneider, Michael Harrington, and Meredith Braskie.
